How to Source Ethamsylate Tablet for Pharmaceutical Formulation
Ethamsylate Tablet (Tablets, 250 mg, 500 mg) is classified under Women's Health. It is therapeutically aligned with reference brands such as Dicynone (USA/EU), Dicynene (India),. This guide highlights key sourcing factors buyers should consider when procuring high-quality Ethamsylate Tablet for formulation, R&D, or bulk manufacturing.
Product Overview:
Ethamsylate is used in the treatment of bleeding. It is used to prevent or reduce bleeding in conditions like abnormal blood loss during periods and dysfunctional uterine bleeding. It also prevents or reduces bleeding during, before or after delicate surgeries. Ethamsylate is a haemostatic medication.
Etamsylate (also spelled ethamsylate) is a hemostatic or anti-hemorrhagic agent widely used to preve...
Ethamsylate Tablet API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Ethamsylate Tablet must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Ethamsylate Tablet is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.
Conclusion
Sourcing Ethamsylate Tablet is more than procurement—it’s a strategic partnership. With its tablets form and 250 mg, 500 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Ethamsylate Tablet.
Request a Quote
Frequently Asked Questions For Sourcing of Ethamsylate Tablet
What is the typical lead time for Ethamsylate Tablet?
Lead times range from 4–6 weeks depending on supplier and region.
Is Ethamsylate Tablet available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Ethamsylate Tablet require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Ethamsylate Tablet?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Ethamsylate Tablet?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Ethamsylate Tablet?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Ethamsylate Tablet suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Ethamsylate Tablet be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our
Privacy Policy.